Skip to content
10-Q

Quarterly Report

OMNI BIO PHARMACEUTICAL, INC.

0001437749-15-002851

← back to feed
Filed
Feb 17, 2015 12:00 AM ET
Period of report
—
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Feb 17, 2015 40.46M sh
Operating Cash Flow Q3 2015 · Dec 31, 2014 −$1.42M
Operating Cash Flow Q3 2015 · Dec 31, 2013 −$1.22M
Cash And Equivalents Q3 2015 · Dec 31, 2014 $852.37K
Cash And Equivalents Q3 2015 · Mar 31, 2014 $271.43K
Cash And Equivalents Q3 2015 · Dec 31, 2013 $485.1K
Cash And Equivalents Q3 2015 · Mar 31, 2013 $343.28K
Stockholders Equity Q3 2015 · Dec 31, 2014 −$2.82M
Stockholders Equity Q3 2015 · Mar 31, 2014 −$884.26K
Current Liabilities Q3 2015 · Dec 31, 2014 $1.6M
Current Liabilities Q3 2015 · Mar 31, 2014 $96.34K
Total Liabilities Q3 2015 · Dec 31, 2014 $3.86M
Total Liabilities Q3 2015 · Mar 31, 2014 $1.38M
Current Assets Q3 2015 · Dec 31, 2014 $921.89K
Current Assets Q3 2015 · Mar 31, 2014 $303.63K
Total Assets Q3 2015 · Dec 31, 2014 $1.03M
Total Assets Q3 2015 · Mar 31, 2014 $496.98K
Sga Expense Q3 2015 · Dec 31, 2014 $410.26K
Sga Expense Q3 2015 · Dec 31, 2014 $1.2M
Sga Expense restated Q3 2015 · Dec 31, 2013 $410.25K
Sga Expense restated Q3 2015 · Dec 31, 2013 $1.45M
Rd Expense Q3 2015 · Dec 31, 2014 $111.91K
Rd Expense Q3 2015 · Dec 31, 2014 $470.69K
Rd Expense Q3 2015 · Dec 31, 2013 $36.25K
Rd Expense Q3 2015 · Dec 31, 2013 $162.84K
Net Income Q3 2015 · Dec 31, 2014 −$1.4M
Net Income Q3 2015 · Dec 31, 2014 −$3.22M
Net Income restated Q3 2015 · Dec 31, 2013 −$755.4K
Net Income restated Q3 2015 · Dec 31, 2013 −$2.08M
Operating Income Q3 2015 · Dec 31, 2014 −$522.16K
Operating Income Q3 2015 · Dec 31, 2014 −$1.67M
Operating Income restated Q3 2015 · Dec 31, 2013 −$446.5K
Operating Income restated Q3 2015 · Dec 31, 2013 −$1.62M